BioMarin Pharmaceutical's total assets for Q1 2024 were $6.87B, an increase of 0.45% from the previous quarter. DE:BM8 total liabilities were $1.80B for the fiscal quarter, a -4.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.